INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1993

Ascorbic acid supplementation was associated with reduced symptom severity in autistic children.

A 30-week double-blind, placebo-controlled trial evaluated ascorbic acid (8g/70kg/day) in 18 autistic children in a residential school. Participants were randomly assigned to an ascorbate-ascorbate-placebo or ascorbate-placebo-ascorbate treatment sequence, with each phase lasting 10 weeks. Weekly ratings on the Ritvo-Freeman scale showed significant group by phase interactions for total scores and sensory motor scores, indicating a reduction in symptom severity associated with ascorbic acid treatment.

Study type
30-week double-blind, placebo-controlled randomized crossover trial
Who was studied
18 autistic children in residential treatment
What was measured
Behaviors rated weekly using the Ritvo-Freeman scale

THE PAPER

A preliminary trial of ascorbic acid as supplemental therapy for autism.

Dolske MC, Spollen J, McKay S, Lancashire E, Tolbert L. Prog Neuropsychopharmacol Biol Psychiatry, 1993.

PubMed 8255984 ↗DOI 10.1016/0278-5846(93)90058-z ↗

Nutrients & adequacyBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.